Clinical trial

Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients

NCT07144241

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-01

PhasePHASE2

Study timeline

Study start (estimated)2025-09-01Date precision: day

Registry last updated2025-08-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Mesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS + 1 vial Exo-HUVEC) TherapyBIOLOGICAL

Mesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS ) TherapyBIOLOGICAL

Sponsors & collaborators

Universitas Indonesialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07144241 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.